ARTICLE | Company News
Kos and DuPont submit NDA
September 26, 2000 7:00 AM UTC
KOSP and DD subsidiary DuPont Pharmaceuticals submitted an NDA to the FDA for a product that combines KOSP's Niaspan extended release niacin with generic lovastatin to improve total lipid levels. In M...